Interpharm
(OTC) IPAH
Interpharm Financials at a Glance
Market Cap
$100
Revenue (TTM)
$69.21M
Net Income (TTM)
$29.36M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-584.91 (Low)
Dividend
$0.00
Beta (Volatility)
-584.91 (Low)
Price
$0.00
Volume
1,750
Open
$0.00
Price
$0.00
Volume
1,750
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
-584.91 (Low)
Price
$0.00
Volume
1,750
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
IPAH News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Interpharm
IPAH Financials
Key Financial Metrics (TTM)
Gross Margin
29%
Operating Margin
-14%
Net Income Margin
-19%
Return on Equity
0%
Return on Capital
-25%
Return on Assets
-19%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
-0.88%
Stock Overview
Market Cap
$100.00
Shares Outstanding
66.74M
Volume
1.75K
Short Interest
0.00%
Avg. Volume
0
Financials (TTM)
Gross Profit
$21.67M
Operating Income
$10.74M
EBITDA
$8.18M
Operating Cash Flow
$14.11M
Capital Expenditure
$8.00M
Free Cash Flow
$22.11M
Cash & ST Invst.
$72.00K
Total Debt
$26.55M
Interpharm Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$16.21M
-7.2%
Gross Profit
$2.27M
-43.8%
Gross Margin
13.99%
N/A
Market Cap
$100.00
N/A
Market Cap/Employee
$0.15
N/A
Employees
670
N/A
Net Income
$10.90M
-164.2%
EBITDA
$2.97M
+18.8%
Quarterly Fundamentals
Net Cash
$38.43M
-340.4%
Accounts Receivable
$13.72M
+20.9%
Inventory
$12.26M
+25.0%
Long Term Debt
$7.79M
-43.5%
Short Term Debt
$30.68M
+1597.0%
Return on Assets
-18.90%
N/A
Return on Invested Capital
-24.53%
N/A
Free Cash Flow
$6.91M
-53.1%
Operating Cash Flow
$6.35M
-96.2%